Persistent infection with hepatitis C virus is a global public health problem that renders health complications ranging from mild liver dysfunction to hepatocellular carcinoma and end-stage liver disease. The virus-host interactions and molecular mechanisms that support persistent HCV replication and chronic infection are not understood, and we hypothesize that persistence is supported in part through viral control of the innate intracellular immune response to infection. Research conducted under this proposal will focus on understanding the molecular processes by which HCV controls the function and antiviral actions of the host cell interferon regulatory 3 (IRF-3), a critical antiviral effector that signals the host response to infection. Our studies have shown that IRF-3 can render control of HCV RNA replication through the antiviral actions of IRF-3 target genes, and that HCV prevents this response through the actions of the viral NS3/4A protease to block virus-induced IRF-3 phosphorylation and activation. We have identified the NS3/4A-IRF-3 interface as a new therapeutic target in which IRF-3 function can be restored through inhibition of NS3/4A protease activity. We have therefore incorporated molecular-genetic, biochemical and pharmacologic approaches to investigate processes and outcomes of NS3/4A regulation of IRF-3. Studies within our Specific Aims will: 1) Define the processes by which NS3/4A controls IRF-3 phosphorylation, activation and function, 2) Define the contribution of IRF-3 action toward the outcome of novel HCV protease inhibitor therapy, 3) Identify host IRF-3 target genes that regulate HCV RNA replication, and 4) Evaluate the sequence and IRF-3 regulatory function of the NS3/4A coding region isolated from chronic HCV patients harboring various viral genotypes. This work will define the role of the IRF-3-NS3/4A interface and the host IRF-3 pathway in controlling HCV RNA replication and determining the outcome of HCV infection. A unique feature of this proposal is the incorporation of studies to evaluate the contribution of the IRF-3 and host antiviral response toward the overall efficiency of novel protease inhibitor therapy for the treatment of HCV infection. Our studies will define the spectrum of IRF-3 target genes in human hepatocytic cells whose products impart control of HCV RNA replication during therapeutic restoration of the host response to infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI060389-06
Application #
7475389
Study Section
Special Emphasis Panel (ZRG1-GMA-2 (50))
Program Officer
Koshy, Rajen
Project Start
2003-09-30
Project End
2008-03-31
Budget Start
2007-06-01
Budget End
2008-03-31
Support Year
6
Fiscal Year
2007
Total Cost
$331,745
Indirect Cost
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Gorman, Jacquelyn A; Hundhausen, Christian; Errett, John S et al. (2017) The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity. Nat Immunol 18:744-752
Li, Junwei; Baird, Madison A; Davis, Michael A et al. (2017) Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine. Nat Biomed Eng 1:
Jarret, Abigail; McFarland, Adelle P; Horner, Stacy M et al. (2016) Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat Med 22:1475-1481
Hong, MeeAe; Schwerk, Johannes; Lim, Chrissie et al. (2016) Interferon lambda 4 expression is suppressed by the host during viral infection. J Exp Med 213:2539-2552
Pattabhi, Sowmya; Wilkins, Courtney R; Dong, Ran et al. (2016) Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway. J Virol 90:2372-87
Altfeld, Marcus; Gale Jr, Michael (2015) Innate immunity against HIV-1 infection. Nat Immunol 16:554-62
Horner, Stacy M; Wilkins, Courtney; Badil, Samantha et al. (2015) Proteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle trafficking. PLoS One 10:e0117963
McFarland, Adelle P; Horner, Stacy M; Jarret, Abigail et al. (2014) The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. Nat Immunol 15:72-9
Ireton, ReneƩ C; Gale Jr, Michael (2014) Pushing to a cure by harnessing innate immunity against hepatitis C virus. Antiviral Res 108:156-64
Horner, Stacy M; Gale Jr, Michael (2013) Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 19:879-88

Showing the most recent 10 out of 56 publications